Skip to content
10-Q

Quarterly Report

SKINOVATION PHARMACEUTICAL INCORPORATED

0001554795-24-000314

← back to feed
Filed
Nov 21, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2024 · Nov 19, 2024 708K sh
Operating Cash Flow Q3 2024 · Sep 30, 2024 −$14.39K
Operating Cash Flow Q3 2024 · Sep 30, 2023 −$7.03K
Cash And Equivalents Q3 2024 · Sep 30, 2024 $1.84K
Cash And Equivalents Q3 2024 · Dec 31, 2023 $16.23K
Stockholders Equity Q3 2024 · Sep 30, 2024 −$483.25K
Stockholders Equity Q3 2024 · Jun 30, 2024 −$472.64K
Stockholders Equity Q3 2024 · Mar 31, 2024 −$462.97K
Stockholders Equity Q3 2024 · Dec 31, 2023 −$447.2K
Stockholders Equity Q3 2024 · Sep 30, 2023 −$438.24K
Stockholders Equity Q3 2024 · Jun 30, 2023 −$430.31K
Stockholders Equity Q3 2024 · Mar 31, 2023 −$422.12K
Stockholders Equity Q3 2024 · Dec 31, 2022 −$411.34K
Current Liabilities Q3 2024 · Sep 30, 2024 $485.1K
Current Liabilities Q3 2024 · Dec 31, 2023 $463.44K
Total Liabilities Q3 2024 · Sep 30, 2024 $485.1K
Total Liabilities Q3 2024 · Dec 31, 2023 $463.44K
Current Assets Q3 2024 · Sep 30, 2024 $1.84K
Current Assets Q3 2024 · Dec 31, 2023 $16.23K
Total Assets Q3 2024 · Sep 30, 2024 $1.84K
Total Assets Q3 2024 · Dec 31, 2023 $16.23K
Sga Expense Q3 2024 · Sep 30, 2024 $4.89K
Sga Expense Q3 2024 · Sep 30, 2024 $18.89K
Sga Expense Q3 2024 · Sep 30, 2023 $2.9K
Sga Expense Q3 2024 · Sep 30, 2023 $11.53K
Net Income Q3 2024 · Sep 30, 2024 −$10.61K
Net Income Q3 2024 · Sep 30, 2024 −$36.05K
Net Income Q3 2024 · Jun 30, 2024 −$9.67K
Net Income Q3 2024 · Mar 31, 2024 −$15.77K
Net Income Q3 2024 · Sep 30, 2023 −$7.94K
Net Income Q3 2024 · Sep 30, 2023 −$26.91K
Net Income Q3 2024 · Jun 30, 2023 −$8.19K
Net Income Q3 2024 · Mar 31, 2023 −$10.78K
Operating Income Q3 2024 · Sep 30, 2024 −$4.89K
Operating Income Q3 2024 · Sep 30, 2024 −$18.89K
Operating Income Q3 2024 · Sep 30, 2023 −$2.9K
Operating Income Q3 2024 · Sep 30, 2023 −$11.53K